Several studies have demonstrated that the GLP-1 receptor agonists such as extendin-4 and liraglutide can activate AMPK signalling in multiple tissues and cell types, including cardiomyocyte hyperglycaemic [20] or cardiac hypertrophy models [21], in rat INS-1 pancreatic beta cells [22], and in L6 myotubes, resulting in the sensitisation of insulin-stimulated glucose uptake [23]
That literature does not convert an RUO material into a clinical, diagnostic, veterinary, or consumer product
2026-03-18T07:00:01 Steris Healthcare Pvt Ltd
confirmed and extended the observation, where GLP-1 significantly increased myocardial glucose uptake under basal conditions in lean humans, but this effect was impaired in T2D [47]
However, the existing research provides intriguing signals that warrant further investigation
Journal of Andrology, 25(5), 683691